Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
N414073-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,180.90 | |
N414073-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,303.90 | |
N414073-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $738.90 | |
N414073-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,116.90 |
DNA-PK Inhibitors
Synonyms | nedisertib|peposertib|1637542-33-6|M3814|MSC2490484A|M-3814|M-3814(nedisertib)|MSC-2490484A|GN429E725A|(S)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol|(~{S})-[2-chloranyl-4-fluoranyl-5-(7-morpholin-4-ylq |
---|---|
Specifications & Purity | 99% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of protein kinase; DNA-activated; catalytic subunit |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol |
---|---|
INCHI | InChI=1S/C24H21ClFN5O3/c1-33-22-5-4-20(29-30-22)24(32)16-11-17(19(26)12-18(16)25)23-15-3-2-14(10-21(15)27-13-28-23)31-6-8-34-9-7-31/h2-5,10-13,24,32H,6-9H2,1H3/t24-/m0/s1 |
InChi Key | MOWXJLUYGFNTAL-DEOSSOPVSA-N |
Canonical SMILES | COC1=NN=C(C=C1)C(C2=C(C=C(C(=C2)C3=NC=NC4=C3C=CC(=C4)N5CCOCC5)F)Cl)O |
Isomeric SMILES | COC1=NN=C(C=C1)[C@H](C2=C(C=C(C(=C2)C3=NC=NC4=C3C=CC(=C4)N5CCOCC5)F)Cl)O |
PubChem CID | 86292849 |
Molecular Weight | 481.91 |
PubChem CID | 86292849 |
---|---|
CAS Registry No. | 1637542-33-6 |
RCSB PDB Ligand | 1IX |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
L2315412 | Certificate of Analysis | Dec 02, 2023 | N414073 |
L2315413 | Certificate of Analysis | Dec 02, 2023 | N414073 |
L2315414 | Certificate of Analysis | Dec 02, 2023 | N414073 |
L2315415 | Certificate of Analysis | Dec 02, 2023 | N414073 |
L2315416 | Certificate of Analysis | Dec 02, 2023 | N414073 |
L2315417 | Certificate of Analysis | Dec 02, 2023 | N414073 |
L2315418 | Certificate of Analysis | Dec 02, 2023 | N414073 |
Solubility | Solubility (25°C) In vitro DMSO: 96 mg/mL (199.2 mM); Ethanol: 2 mg/mL (4.15 mM); Water: Insoluble; |
---|
1. Harnor SJ, Brennan A, Cano C. (2017) Targeting DNA-Dependent Protein Kinase for Cancer Therapy.. ChemMedChem, 12 (12): (895-900). [PMID:28423228] |
2. Klein C, Dokic I, Mairani A, Mein S, Brons S, Häring P, Haberer T, Jäkel O, Zimmermann A, Zenke F et al.. (2017) Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.. Radiat Oncol, 12 (1): (208). [PMID:29287602] |